Job moves

Gulliver to oversee HSBC’s derivatives business HSBC has appointed Stuart Gulliver (right) and John Studzinski as co-heads of corporate, investment banking and markets business (CIBM). Gulliver will be responsible for foreign exchange, fixed income, syndicated loans, structured credit, precious metals, equities and all derivatives. Studzinski will be responsible for global relationship management, corporate banking, corporate finance and debt and equity capital markets origination. Gulliver previously managed HSBC’s global markets business, having been appointed to that role last year, and relocates from Hong Kong to London. He has worked at HSBC since 1980 in various roles, including forex sales chief in Hong Kong, treasurer in Tokyo and manager of group treasury in London. Studzinski joins HSBC from Morgan Stanley International, where he was deputy chairman in London. Gulliver and Studzinski report to Stephen Green, former executive director of CIBM, who becomes chief executive of HSBC Group on May 30.

-tuart-ulliver-jpg

Michael Ong, former chief risk officer for the Americas at Credit Agricole Indosuez, has moved into academia with a full professorship and directorship on the finance programme at the Illinois Institute of Technology in Chicago.

Prior to joining Credit Agricole, Ong was head of enterprise risk management at ABN Amro. His recent research has covered a spectrum of issues related to risk management and derivatives, including credit risk, operational risk and the role

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here